| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5692592 | European Urology | 2016 | 5 Pages |
Abstract
Erectile dysfunction medications are not associated with a higher risk of disease recurrence after prostate cancer treatment.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Stacy Loeb, Yasin Folkvaljon, David Robinson, Thorsten Schlomm, Hans Garmo, Pär Stattin,